September JNM Supplement Highlights Theranostics

September 8, 2017

The Journal of Nuclear Medicine’s September 2017 supplement on Clinical and Translational Theranostics shines a spotlight on theranostics and its increasingly important role in the delivery of precision medicine.

In Memoriam: Dirk J. Kwekkeboom (1958–2017)

Lisa Bodei

Theranostic Concepts: More Than Just a Fashion Trend—Introduction and Overview

KKKen Herrmann, Steven M. Larson, and Wolfgang A. Weber

Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine

Rachel Levine and Eric P. Krenning

Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications

Jean Claude Reubi and Helmut R. Maecke

Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn, and John Babich

Identification of Ligands and Translation to Clinical Applications

Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann, and John Babich

Iodine Symporter Targeting with 124I/131I Theranostics

James Nagarajah, Marcel Janssen, Philipp Hetkamp, and Walter Jentzen

Norepinephrine Transporter as a Target for Imaging and Therapy

Neeta Pandit-Taskar and Shakeel Modak

Somatostatin Receptor 2–Targeting Compounds

Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom, and Lisa Bodei

Somatostatin Receptor Antagonists for Imaging and Therapy

Melpomeni Fani, Guillaume P. Nicolas, and Damian Wild

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann, and Frederik L. Giesel

CXCR4 Ligands: The Next Big Hit?

Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann, and Hans-Jürgen Wester

Theranostics Using Antibodies and Antibody-Related Therapeutics

Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers, and Elisabeth G.E. de Vries

Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β-Particle, and Auger Electron Emitters

Cristina Müller, Nicholas P. van der Meulen, Martina Benešová, and Roger Schibli

Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?

Uta Eberlein, Marta Cremonesi, and Michael Lassmann

Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes

Edward Boas, Lisa Bodei, and Constantinos T. Sofocleous